|
PDPR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.284200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.907000E-01 |
| Normal-vs-Stage2 |
9.018800E-04 |
| Normal-vs-Stage3 |
2.202700E-04 |
| Normal-vs-Stage4 |
3.94559999999933E-05 |
| Stage1-vs-Stage2 |
1.784290E-03 |
| Stage1-vs-Stage3 |
4.151800E-04 |
| Stage1-vs-Stage4 |
5.98210000000154E-05 |
| Stage2-vs-Stage3 |
9.514000E-01 |
| Stage2-vs-Stage4 |
3.537800E-01 |
| Stage3-vs-Stage4 |
3.462800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.736200E-03 |
| Normal-vs-AfricanAmerican |
1.830480E-02 |
| Normal-vs-Asian |
5.088200E-01 |
| Caucasian-vs-AfricanAmerican |
4.188600E-01 |
| Caucasian-vs-Asian |
8.360000E-01 |
| AfricanAmerican-vs-Asian |
5.911800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.427500E-04 |
| Normal-vs-Female |
4.090800E-01 |
| Male-vs-Female |
7.155700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.829600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.049500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.798800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.602990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.461800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.357600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.830000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.483410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.379400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.021600E-01 |
| Normal-vs-Grade 2 |
3.515200E-01 |
| Normal-vs-Grade 3 |
4.177600E-03 |
| Normal-vs-Grade 4 |
2.84290000429621E-08 |
| Grade 1-vs-Grade 2 |
2.597400E-01 |
| Grade 1-vs-Grade 3 |
5.488300E-02 |
| Grade 1-vs-Grade 4 |
2.433200E-04 |
| Grade 2-vs-Grade 3 |
3.904100E-02 |
| Grade 2-vs-Grade 4 |
3.37000000016907E-07 |
| Grade 3-vs-Grade 4 |
8.016300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.221800E-01 |
| Normal-vs-ccB subtype |
3.59109999999996E-05 |
| ccA subtype-vs-ccB subtype |
3.96839999972087E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.013810E-02 |
| Normal-vs-N1 |
1.460180E-01 |
| N0-vs-N1 |
5.025000E-01 |
|
|
